Moderna, U.S. Reach Deal for 100 Million Covid-19 Vaccine Doses
An automated pipetting machine sits at the Institute for Protein Innovation, a nonprofit founded by Harvard Medical School professor Timothy Springer, in Boston, Massachusetts, U.S. (Photographer: Scott Eisen/Bloomberg)

Moderna, U.S. Reach Deal for 100 Million Covid-19 Vaccine Doses

(Bloomberg) -- Moderna Inc. reached a deal with the Trump administration to supply 100 million doses of its experimental vaccine for Covid-19, in a pact valued at up to $1.5 billion, the latest in ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.